| Literature DB >> 35318371 |
Jules R Dugré1,2, Simon B Eickhoff3,4, Stéphane Potvin5,6.
Abstract
In the last decades, neuroimaging studies have attempted to unveil the neurobiological markers underlying pediatric psychiatric disorders. Yet, the vast majority of neuroimaging studies still focus on a single nosological category, which limit our understanding of the shared/specific neural correlates between these disorders. Therefore, we aimed to investigate the transdiagnostic neural correlates through a novel and data-driven meta-analytical method. A data-driven meta-analysis was carried out which grouped similar experiments' topographic map together, irrespectively of nosological categories and task-characteristics. Then, activation likelihood estimation meta-analysis was performed on each group of experiments to extract spatially convergent brain regions. One hundred forty-seven experiments were retrieved (3124 cases compared to 3100 controls): 79 attention-deficit/hyperactivity disorder, 32 conduct/oppositional defiant disorder, 14 anxiety disorders, 22 major depressive disorders. Four significant groups of experiments were observed. Functional characterization suggested that these groups of aberrant brain regions may be implicated internally/externally directed processes, attentional control of affect, somato-motor and visual processes. Furthermore, despite that some differences in rates of studies involving major depressive disorders were noticed, nosological categories were evenly distributed between these four sets of regions. Our results may reflect transdiagnostic neural correlates of pediatric psychiatric disorders, but also underscore the importance of studying pediatric psychiatric disorders simultaneously rather than independently to examine differences between disorders.Entities:
Mesh:
Year: 2022 PMID: 35318371 PMCID: PMC8941086 DOI: 10.1038/s41598-022-08909-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Workflow of the current study. Step 1: Creation of a MA map for each experiment, weighted by sample size. Step 2: Pairwise Spearman Rho correlation was performed between every MA map. Step 3: Clustering analysis was performed on the correlation matrix to extract groups of experiments sharing similar MA map. Step 4: ALE meta-analysis was conducted on experiments within each group. Phenotype assessment was then carried out to investigate under/over-representativeness of disorders, sample and task characteristics across identified groups.
Figure 2Hierarchical clustering of aberrant activation maps. This dendrogram represents the final hierarchical clustering model which grouped experiment showing similar aberrant activation maps. The 4 significant meta-analytical groupings (MAGs) represented 90.58% of total sample of experiments: MAG1 (green) = 21 experiments and 577 subjects; MAG2 (black) = 87 experiments (1848 subjects); MAG3 = 13 experiments (197 subjects) & MAG4 (cyan) = 12 experiments (278 subjects).
ALE meta-analysis results of each significant groups of experiments.
| MAGs | Clusters | Size (mm3) | MNI coordinates | ALE | Cluster breakdown | ||
|---|---|---|---|---|---|---|---|
| X | Y | Z | |||||
| MAG1 | 1 | 2456 | 14 | 46 | 28 | 0.0175 | R dmPFC (rostrodorsal) |
| 2 | 1152 | − 16 | 56 | 22 | 0.0154 | L dmPFC (caudal) | |
| 3 | 1096 | − 24 | − 60 | − 28 | 0.0177 | L Cerebellum (Lobule VI) | |
| 4 | 1048 | 30 | 40 | 46 | 0.0164 | R dlPFC | |
| 5 | 848 | 58 | − 8 | − 18 | 0.0216 | R MTG/STG | |
| MAG2 | 1 | 1352 | 8 | 18 | 40 | 0.0243 | R aMCC (Area 32')/pre-SMA |
| 2 | 1296 | − 20 | − 10 | − 16 | 0.0272 | L Amygdala | |
| 3 | 1040 | − 2 | 12 | 22 | 0.0321 | L dACC (Area 24a'-b') | |
| MAG3 | 1 | 976 | 34 | − 26 | 52 | 0.0125 | R Pre-/Postcentral gyri (Area 2–3 & 4p) |
| 2 | 800 | 46 | − 34 | 44 | 0.0133 | R Supramarginal gyrus (Area 2, PFt) | |
| 3 | 720 | − 42 | − 32 | 42 | 0.0112 | L Postcentral gyrus (Area 2, PFt) | |
| MAG4 | 1 | 2336 | 20 | − 78 | − 12 | 0.0172 | R Lingual (h0c3v) |
| 2 | 1224 | − 18 | − 66 | − 24 | 0.0159 | L Cerebellum (Lobule V1) | |
| 3 | 968 | 44 | − 58 | − 4 | 0.0168 | R pMTG | |
| 4 | 912 | − 44 | − 48 | − 14 | 0.0151 | L pITG | |
| 5 | 736 | − 8 | − 62 | 6 | 0.0186 | L Calcarine Cortex | |
| 6 | 728 | 40 | − 52 | − 26 | 0.0155 | R Cerebellum (Lobule VI) | |
MAG meta-analytical grouping, PFC prefrontal cortex, dmPFC dorsomedial PFC, dlPFC dorsolateral PFC, MTG middle temporal gyrus, STG superior temporal gyrus, aMCC anterior midcingulate cortex, pre-SMA pre-supplementary motor area, dACC dorsal anterior cingulate cortex, IPL Inferior Parietal Lobule, SPL superior parietal lobule, pMTG posterior MTG, pITG posterior ITG.
Figure 3ALE meta-analysis on each significant meta-analytical grouping (MAGs). Images are shown for left hemisphere (lateral), superior view and right hemisphere (lateral) respectively. ALE images were thresholded at p < 0.001 at the voxel-level and pFWE > 0.05. Word clouds were generated using BrainMap database terms (Behavioral Subdomains & Paradigm). Font size represents Z-score associated with the whole MAG (all words are significant p = 0.05 with Bonferroni correction).
Characteristics of Experiments across meta-analytical groupings.
| Characteristics | Total (n = 147) | MAG1 (k = 21) | MAG2 (k = 87) | MAG3 (k = 13) | MAG4 (k = 12) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | n | % | |
| ADHD | 79 | 53.7% | 14 | 66.7% | 43 | 49.4% | 8 | 61.5% | 8 | 66.7% |
| CD | 32 | 21.8% | 4 | 19.0% | 17 | 19.5% | 4 | 30.8% | 3 | 25.0% |
| ANX | 14 | 9.5% | 3 | 14.3% | 9 | 10.3% | 0 | 0.0% | 1 | 8.3% |
| DEP | 22 | 15.0% | 0*† | 0.0% | 18† | 20.7% | 1 | 7.7% | 0 | 0.0% |
| Cognitive | 88 | 59.9% | 10 | 47.6% | 53 | 60.9% | 9 | 69.2% | 10 | 83.3% |
| Response Inhibition | 44 | 29.9% | 7 | 33.3% | 29 | 33.3% | 3 | 23.1% | 4 | 33.3% |
| Attention | 23 | 15.6% | 1 | 4.8% | 13 | 14.9% | 3 | 23.1% | 3 | 25.0% |
| Emotion | 71 | 48.3% | 12 | 57.1% | 42 | 48.3% | 3* | 23.1% | 5 | 41.7% |
| Positive | 17 | 11.6% | 6*† | 28.6% | 7* | 8.0% | 0 | 0.0% | 1 | 8.3% |
| Negative | 37 | 25.2% | 4 | 19.0% | 24 | 27.6% | 1 | 7.7% | 2 | 16.7% |
| Both | 16 | 10.9% | 2 | 9.5% | 10 | 11.5% | 2 | 15.4% | 2 | 16.7% |
| Medication-Naïve | 61 | 41.5% | 14† | 66.7% | 40 | 46.0% | 6 | 46.2% | 5 | 41.7% |
| Average Med per sample | – | 26.7% | – | 35.2% | – | 26.3% | – | 19.4% | – | 20.9% |
| Mixed Sex Sample | 95 | 64.6% | 12 | 57.1% | 60 | 69.0% | 7 | 53.8% | 8 | 66.7% |
| Average Boys per Sample | – | 71.7% | – | 77.6% | – | 71.4% | – | 76.1% | – | 61.1% |
*Represents significant difference compared to its base rate (one-tailed p < 0.05). † Represents significant differences between MAGs (p < 0.05).